Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer, Novartis and more post price hikes on dozens of drugs, but AbbVie’s is worth the most
Pfizer, Novartis and more post price hikes on dozens of drugs, but AbbVie’s is worth the most
Pfizer, Novartis and more post price hikes on dozens of drugs, but AbbVie’s is worth the most
Submitted by
admin
on January 4, 2018 - 10:27pm
Source:
Fierce Pharma
News Tags:
drug pricing
Pfizer
Novartis
AbbVie
Headline:
Pfizer, Novartis and more post price hikes on dozens of drugs, but AbbVie’s is worth the most
Do Not Allow Advertisers to Use My Personal information
